Neurizon inks $1.5M loan against R&D Tax Rebate
Neurizon Therapeutics (ASX:NUZ) retreated in intra-day trade on Wednesday after inking a non-dilutive loan agreement for $1.5 million to fund its current and future operations seeking to treat Huntington’s with its flagship drug NUZ-001.The funds in question are secured against it...
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
SCA | Ann: SCG Operating Update | 07/05/25 | 0 | 117 | |||
|
|||||||
SCA | Ann: 2024 SGT1, SGT2 and SGT3 Annual Financial Reports | 18/03/25 | 0 | 169 | |||
|
|||||||
SCA | Ann: SCG Full Year Announcement and Results Presentation | 26/02/25 | 0 | 144 | |||
|
|||||||
SCA | Ann: SCG Appendix 4E and 2024 Annual Financial Report | 26/02/25 | 0 | 149 | |||
|
|||||||
SCA | Ann: SCG 3rd Quarter Operational Update | 07/11/24 | 0 | 253 | |||
|
|||||||
SCA | Ann: Director Appointment - Craig Mitchell | 14/10/24 | 0 | 240 | |||
|
|||||||
SCA | Ann: 2024 SGT1, SGT2 and SGT3 Half-Year Financial Reports | 21/08/24 | 0 | 239 | |||
|
|||||||
SCA | Ann: SCG Half Year Results Announcement and Slide Presentation | 21/08/24 | 0 | 279 | |||
|
See All Discussions
Timeline
![]() |
|
||||
![]() |
|
||||
![]() |
|
||||
![]() |
|
||||
![]() |
|
||||
![]() |
|
||||
View More |